Press-release for stocks for centogene n.v. for abt

| -2.53% | O: -0.99% H: 0.88% C: -0.52%
DGX | $128.44 2.01% 0.0% 1.6M

| -1.99% | O: 0.01% H: 0.55% C: -1.66%
QGEN | $40.0 1.34% 0.0% 1.1M

| -10.47% | O: -1.64% H: 0.58% C: -0.56%
BIO | $279.73 -0.46% 0.0% 290K

| -16.4% | O: -1.32% H: 0.37% C: -1.83%
BDX | $234.12 0.42% 0.0% 1.3M

| -5.08% | O: 0.04% H: 0.72% C: -1.81%
A | $132.73 0.22% 0.0% 1.3M

| 2.82% | O: -2.03% H: 1.0% C: -0.44%
ABT | News | $107.28 1.91% 0.18% 10M

| -4.6% | O: 0.94% H: 0.0% C: 0.0%
QGEN | $40.0 1.34% 0.0% 1.1M

| -10.47% | O: -1.64% H: 0.58% C: -0.56%
MYGN F | $18.515 0.03% 0.03% 490K

| -19.13% | O: -3.99% H: 1.49% C: -3.71%
ILMN | $117.43 0.63% 0.63% 1.4M

| -15.48% | O: -2.48% H: 1.08% C: -2.01%
CNTG | $0.463 0.43% 0.43% 79K

| -50.25% | O: 2.59% H: 0.0% C: -11.11%
cancer biomarkers growth market

Global Clinical Biomarkers Market Report 2023: Technological Advancements and Rise in R&D Activities Fuels the Sector
Published: 2023-07-03 (Crawled : 19:00) - prnewswire.com
ABCZF | $22.1 -2.32% 4K

| Email alert Add to watchlist
CRL | $226.78 -0.34% 0.0% 410K

| Email alert Add to watchlist
CNTG | $0.463 0.43% 0.43% 79K

| Email alert Add to watchlist
MYGN F | $18.515 0.03% 0.03% 490K

| Email alert Add to watchlist
ILMN | $117.43 0.63% 0.63% 1.4M

| Email alert Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M

| Email alert Add to watchlist
A | $132.73 0.22% 0.0% 1.3M

| Email alert Add to watchlist
ABCM | $23.99 0.0% 7.4M

| Email alert Add to watchlist
BIO | $279.73 -0.46% 0.0% 290K

| Email alert Add to watchlist
report global biomarkers market

The Global Cancer Biomarkers Market to Upsurge at a Tremendous CAGR of ~14% by 2027 | DelveInsight
Published: 2023-02-13 (Crawled : 16:00) - prnewswire.com
QGEN | $40.0 1.34% 0.0% 1.1M

| -20.28% | O: -1.34% H: 1.01% C: 0.6%
BIO | $279.73 -0.46% 0.0% 290K

| -42.1% | O: 0.45% H: 0.68% C: -0.29%
ABBV | $166.41 1.06% 0.0% 5.5M

| 8.62% | O: -0.02% H: 1.16% C: 1.12%
ABT | News | $107.28 1.91% 0.18% 10M

| -1.63% | O: 0.15% H: 0.76% C: 0.18%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -4.43% | O: -1.53% H: 0.0% C: 0.0%
QGEN | $40.0 1.34% 0.0% 1.1M

| -20.28% | O: -1.34% H: 1.01% C: 0.6%
ILMN | $117.43 0.63% 0.63% 1.4M

| -39.83% | O: 0.17% H: 9.75% C: 9.66%
HOLX | $75.37 0.36% 0.36% 1.3M

| -8.48% | O: 0.23% H: 1.74% C: 1.72%
EXAS | $60.97 -3.95% -4.12% 2.2M

| -0.3% | O: 0.55% H: 1.69% C: 1.57%
CNTG | $0.463 0.43% 0.43% 79K

| -62.78% | O: 0.0% H: 3.88% C: -1.55%
global biomarkers cancer market

Global $3.25+ Billion Lung Cancer Genomic Testing Markets to 2031: Focus on Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
Published: 2022-06-23 (Crawled : 11:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M

| -5.15% | O: 0.43% H: 2.47% C: 1.85%
QGEN | $40.0 1.34% 0.0% 1.1M

| -8.79% | O: 1.72% H: 0.0% C: 0.0%
LH M | $201.48 1.02% 0.0% 770K

| -12.7% | O: 2.35% H: 2.94% C: 2.21%
NVTA | $0.019 0.0% 22M

| -99.23% | O: 0.4% H: 13.31% C: 13.31%
A | $132.73 0.22% 0.0% 1.3M

| 21.02% | O: 1.38% H: 3.62% C: 3.49%
ABT | News | $107.28 1.91% 0.18% 10M

| 2.8% | O: 2.4% H: 0.0% C: 0.0%
VCYT | $19.43 1.2% 1.18% 1.4M

| 2.45% | O: 0.75% H: 15.68% C: 15.57%
QGEN | $40.0 1.34% 0.0% 1.1M

| -8.79% | O: 1.72% H: 0.0% C: 0.0%
OPK | $1.23 0.0% 2.7M

| -50.6% | O: 0.0% H: 6.02% C: 5.62%
ILMN | $117.43 0.63% 0.63% 1.4M

| -34.59% | O: 1.66% H: 0.0% C: 0.0%
CNTG | $0.463 0.43% 0.43% 79K

| -77.14% | O: -4.76% H: 34.5% C: 3.0%
genomic cancer

Global Cancer Biomarkers Market Research Report 2022
Published: 2022-04-21 (Crawled : 12:20) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M

| -7.42% | O: 2.95% H: 0.0% C: 0.0%
QGEN | $40.0 1.34% 0.0% 1.1M

| -15.47% | O: 1.81% H: 0.0% C: 0.0%
PKI | $115.24 0.0% 1.6M

| -27.82% | O: 2.81% H: 0.0% C: 0.0%
BIO | $279.73 -0.46% 0.0% 290K

| -50.89% | O: 1.54% H: 0.0% C: 0.0%
BDX | $234.12 0.42% 0.0% 1.3M

| -12.82% | O: 1.5% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

| -10.87% | O: 3.21% H: 0.0% C: 0.0%
QGEN | $40.0 1.34% 0.0% 1.1M

| -15.47% | O: 1.81% H: 0.0% C: 0.0%
MYGN F | $18.515 0.03% 0.03% 490K

| -18.57% | O: 1.31% H: 0.0% C: 0.0%
ILMN | $117.43 0.63% 0.63% 1.4M

| -65.66% | O: 0.85% H: 0.0% C: 0.0%
HOLX | $75.37 0.36% 0.36% 1.3M

| -2.23% | O: 2.17% H: 0.0% C: 0.0%
CNTG | $0.463 0.43% 0.43% 79K

| -88.35% | O: -2.66% H: 1.25% C: 1.25%
research report cancer market biomarkers

Precision Cardiology Market To Generate $2,998.4 Million Revenue by 2030, says P&S Intelligence
Published: 2022-04-19 (Crawled : 09:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M

| -6.3% | O: 1.04% H: 0.22% C: -0.11%
ABT | News | $107.28 1.91% 0.18% 10M

| -9.25% | O: -0.45% H: 0.0% C: 0.0%
EXAS | $60.97 -3.95% -4.12% 2.2M

| -7.45% | O: -2.06% H: 4.31% C: 2.07%
CNTG | $0.463 0.43% 0.43% 79K

| -88.6% | O: -1.43% H: 0.0% C: -2.65%
cardiology market

Global Comprehensive Metabolic Panel Testing Market to 2027 - by Disease, Test Type, Test Type, End-user and Region
Published: 2022-03-23 (Crawled : 15:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M

| -11.38% | O: -0.68% H: 0.32% C: -0.31%
LH M | $201.48 1.02% 0.0% 770K

| -27.92% | O: -0.44% H: 0.17% C: -1.64%
ABT | News | $107.28 1.91% 0.18% 10M

| -12.75% | O: -0.64% H: 0.0% C: 0.0%
OPK | $1.23 0.0% 2.7M

| -65.83% | O: -1.94% H: 1.98% C: -2.27%
CNTG | $0.463 0.43% 0.43% 79K

| -88.62% | O: -0.95% H: 4.78% C: -1.91%
metabolic test market disease

Cancer Biomarkers Market worth $28.2 billion by 2026 - Exclusive Report by MarketsandMarkets™
Published: 2022-03-18 (Crawled : 16:00) - prnewswire.com
QGEN | $40.0 1.34% 0.0% 1.1M

| -19.64% | O: -1.76% H: 4.73% C: 4.13%
PKI | $115.24 0.0% 1.6M

| -34.79% | O: -0.43% H: 2.91% C: 2.7%
BIO | $279.73 -0.46% 0.0% 290K

| -52.55% | O: -0.66% H: 3.27% C: 3.01%
BDX | $234.12 0.42% 0.0% 1.3M

| -11.03% | O: 0.68% H: 0.55% C: 0.24%
ABT | News | $107.28 1.91% 0.18% 10M

| -12.21% | O: -0.26% H: 0.0% C: 0.0%
QGEN | $40.0 1.34% 0.0% 1.1M

| -19.64% | O: -1.76% H: 4.73% C: 4.13%
MYGN F | $18.515 0.03% 0.03% 490K

| -26.15% | O: -0.32% H: 5.68% C: 3.46%
ILMN | $117.43 0.63% 0.63% 1.4M

| -65.03% | O: -0.4% H: 0.0% C: 0.0%
HOLX | $75.37 0.36% 0.36% 1.3M

| 1.38% | O: 0.24% H: 1.24% C: 1.12%
CNTG | $0.463 0.43% 0.43% 79K

| -88.0% | O: 0.0% H: 3.0% C: 2.75%
report cancer biomarkers

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

Finance

EGOX | $0.0515 43.06% 30.1% 330M

OLB 4 | $0.33 -14.95% 25.53% 840K

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M